Stockreport

Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data

Palisade Bio, Inc.  (PALI) 
PDF PALI-2108 demonstrated favorable safety, with no serious adverse events, lab abnormalities, or EKG concerns Phase 1b data demonstrated 100% clinical response and promis [Read more]